InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| ssRNA40/LyoVec™ | Antiphospholipid antibody-induced trophoblast responses are differentially mo... | 2021 | Am J Reprod Immunol | DeSpenza R.A. et al. | DOI: 10.1111/aji.13516 |
| B16-Blue™ ISG-KO-STING Cells | An alternatively spliced STING isoform localizes in the cytoplasmic membrane ... | 2021 | J Clin Invest | Li X. et al. | DOI: 10.1172/JCI144339 |
| c-di-GMP | An alternatively spliced STING isoform localizes in the cytoplasmic membrane ... | 2021 | J Clin Invest | Li X. et al. | DOI: 10.1172/JCI144339 |
| 2'3'-cGAMP | An alternatively spliced STING isoform localizes in the cytoplasmic membrane ... | 2021 | J Clin Invest | Li X. et al. | DOI: 10.1172/JCI144339 |
| ODN 1826 - TLR9 ligand | Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd... | 2022 | Biomaterials | He H. et al. | DOI: 10.1016/j.biomaterials.2021.121272 |
| R848 (Resiquimod) | SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibro... | 2021 | Cell | Wendisch D. et al. | DOI: 10.1016/j.cell.2021.11.033 |
| 3p-hpRNA - RIG-I agonist | SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibro... | 2021 | Cell | Wendisch D. et al. | DOI: 10.1016/j.cell.2021.11.033 |
| 3-Methyladenine | Investigation of the role of the autophagic protein LC3B in the regulation of... | 2021 | Mater Today Bio | Chen S.L. et al. | DOI: 10.1016/j.mtbio.2021.100182 |
| Human IL-1α & IL-1β Reporter HEK 293 Cells | First-in-human phase 1 dose-escalation study of CAN04, a first-in-class inter... | 2021 | Br J Cancer | Robbrecht D. et al. | DOI: 10.1038/s41416-021-01657-7 |
| Mouse TLR5 Reporter HEK293 Cells (NF-κB) | Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants... | 2021 | Microb Pathog | Swain B. et al. | DOI: 10.1016/j.micpath.2021.105355 |
| HEK-Blue™ Detection | Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants... | 2021 | Microb Pathog | Swain B. et al. | DOI: 10.1016/j.micpath.2021.105355 |
| Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants... | 2021 | Microb Pathog | Swain B. et al. | DOI: 10.1016/j.micpath.2021.105355 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavio... | 2021 | Brain Behav Immun | Frank M.G. et al. | DOI: 10.1016/j.bbi.2021.12.007 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavio... | 2021 | Brain Behav Immun | Frank M.G. et al. | DOI: 10.1016/j.bbi.2021.12.007 |
| EndoFit™ OVA protein | Combined delivery of TLR2 and TLR7 agonists by Nanostructured Lipid Carriers ... | 2021 | Int J Pharm | Kaur A. et al. | DOI: 10.1016/j.ijpharm.2021.121378 |
| Hygromycin B Gold | Regeneration of immunocompetent B lymphopoiesis from pluripotent stem cells g... | 2021 | Cell Mol Immunol. | Zhang Q. et al. | DOI: 10.1038/s41423-021-00805-6 |
| MDP | DNA methyltransferase inhibitors increase NOD-like receptor activity and expr... | 2021 | Immunopharmacol Immunotoxicol | Feerick C.L. & McKernan D.P. | DOI: 10.1080/08923973.2021.2007264 |
| Tri-DAP | DNA methyltransferase inhibitors increase NOD-like receptor activity and expr... | 2021 | Immunopharmacol Immunotoxicol | Feerick C.L. & McKernan D.P. | DOI: 10.1080/08923973.2021.2007264 |
| iE-DAP | DNA methyltransferase inhibitors increase NOD-like receptor activity and expr... | 2021 | Immunopharmacol Immunotoxicol | Feerick C.L. & McKernan D.P. | DOI: 10.1080/08923973.2021.2007264 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis vi... | 2021 | EBioMedicine | Luo Y. et al. | DOI: 10.1016/j.ebiom.2021.103725 |